ADHD Medication Poisonings Rising in Australia

ADHD Medication Poisonings Rising in Australia

12 Nov 2025

ADHD Medication Poisonings Rising in Australia

Poisonings from medications used to treat attention deficit hyperactivity disorder (ADHD) have increased fourfold in the past decade, highlighting the role of GPs in educating families about safe use.

A University of Sydney study found reported poisonings rose from 795 in 2014 to 3,242 in 2023, with children under 15 accounting for 72% of accidental exposures. The research examined six common ADHD medications — atomoxetine, clonidine, dexamphetamine, guanfacine, lisdexamfetamine, and methylphenidate — and found a strong correlation between poisonings and prescription numbers.

Clonidine and methylphenidate were responsible for 35% of poisonings each, with clonidine incidents disproportionately high compared to prescription rates. Lead author Amy Thomson noted dosing errors, family miscommunication, and children accessing siblings’ medication as key risks.

RACGP experts emphasised the importance of GPs educating families on safe medication practices. Dr Tim Jones said smaller tablet doses and limited prescription quantities for children could help reduce risk. Associate Professor John Kramer added that while clonidine is effective and affordable, it must be used carefully, particularly in young patients.

“GPs need to guide families on proper dosing, potential risks, and safe storage,” Dr Jones said. “Our role as educators is critical to prevent accidental harm.”

Source: RACGP newsGP

 

Categories

Popular Posts

Tags